Harnessing genomic profiling for precision breast cancer therapies: Advances in HER2-targeted treatments, PARP inhibitors for BRCA mutations, and insights from clinical trials

Biomedical Research and Therapy · Published 2026-02-28 · DOI 10.15419/v1dhqx66

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.15419/v1dhqx66

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles